Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2010
06/03/2010US20100137209 Modified plasminogen activator inhibitor type-1 and methods based thereon
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100137189 Modified globin proteins with altered electron transport pathway
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136146 Composition for heart disease, its active ingredients, method to prepare same and uses thereof
06/03/2010US20100136142 Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136119 Controlled-release preparation containing cilostazol and process for the preparation thereof
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136035 Method for modulating atherosclerosis
06/03/2010US20100136021 Tgf-beta binding antibodies
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof
06/03/2010US20100135970 Methods for Reprogramming Adult Somatic Cells and Uses Thereof
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010CA2748344A1 Enhanced bioactive formulations of resveratrol
06/03/2010CA2744857A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug
06/03/2010CA2744828A1 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of 3-(3'-carboxy-4'-hydroxy-anilino-carbo-)-6-nitro-7-hydroxy-8-methyl-coumarin)>>
06/03/2010CA2744505A1 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
06/03/2010CA2744309A1 Rocaglaol derivatives as cardioprotectant agents and as antineoplastic agents
06/03/2010CA2744178A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010CA2744021A1 Nitrooxy cycloalkane derivatives
06/03/2010CA2743887A1 Transdermally administered aliskiren
06/03/2010CA2741731A1 Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation
06/02/2010EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I
06/02/2010EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i>
06/02/2010EP2191838A1 Erythropoetin for the stimulation of endothelial precursor cells
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191823A1 Methods for improving bioavailability of a renin inhibitor
06/02/2010EP2190843A1 Benzimidazole nf- kappab inhibitors
06/02/2010EP2190837A1 4-pyrimidinesulfamide derivative
06/02/2010EP2190827A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
06/02/2010EP2190814A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
06/02/2010EP2190810A1 Compounds isolated from antrodia cinnamomea and use thereof
06/02/2010EP2190464A2 Use of leptin(22-56) as a therapeutic agent
06/02/2010EP2190463A2 Use of thymopentin as a therapeutic agent
06/02/2010EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
06/02/2010EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
06/02/2010EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
06/02/2010EP2190452A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190451A1 Treatment of atherosclerosis
06/02/2010EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
06/02/2010EP2190430A1 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
06/02/2010EP2102207B1 Spiro-piperidine derivatives as via receptor antagonists
06/02/2010EP2099799B1 Spiro-piperidine derivatives
06/02/2010EP1928993B1 Proanthocyanidin tannin composition, production method thereof and use of same
06/02/2010EP1831211B1 Indazole-carboxamide compounds
06/02/2010EP1541553B1 Indoline compound and medicinal use thereof
06/02/2010CN1957927B Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN1823799B Erigeron breviscapus slow release agent and its preparation method
06/02/2010CN1659180B Novel recombinant anticoagulant proteins
06/02/2010CN101720224A 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
06/02/2010CN101717761A Application of lumbrukinase in treating carotid atherosclerosis
06/02/2010CN101717730A Method for reducing cane sugar content in molasses
06/02/2010CN101717711A Five-step wind-dispelling wine and preparation method thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101717398A Sophocarpine-series derivative as well as preparation method and purposes thereof
06/02/2010CN101717384A Compound in salvia miltiorrhiza bungered sage root injection and application thereof in curing treating cardiovascular disease
06/02/2010CN101717382A Method for synthesizing cinepazide
06/02/2010CN101717359A Method for synthesizing indapamide
06/02/2010CN101716334A Biological medicament for treating ischemic cardiovascular disease and skin ulcer
06/02/2010CN101716330A Traditional Chinese medicine composition for treating angina disease and preparation method thereof
06/02/2010CN101716322A Traditional Chinese medicine composition for treating heart-blood deficiency disease and preparation method thereof
06/02/2010CN101716321A Traditional Chinese medicine composition for treating heart vessel blockage stasis disease and preparation method thereof
06/02/2010CN101716308A Quality control method of calculus bovis antihypertensive pills
06/02/2010CN101716289A Traditional Chinese medicine preparation for treating ischemic diseases
06/02/2010CN101716286A Traditional Chinese medicine composition for treating hemorrhagic stroke
06/02/2010CN101716284A Blood-pressure regulating medicine
06/02/2010CN101716271A Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof
06/02/2010CN101716269A Traditional Chinese medicine composition for treating hyperpiesia
06/02/2010CN101716264A Medical composition for treating atherosclerosis, preparation method and application thereof
06/02/2010CN101716255A Medicinal composition with function of protecting optic nerve and preparation method and application thereof
06/02/2010CN101716254A Compound thrombus-clearing Chinese medicinal preparation and preparation method thereof
06/02/2010CN101716253A Chinese medicinal preparation containing panax notoginseng, and preparation method thereof
06/02/2010CN101716248A Traditional Chinese medicine composition for treating diabetes mellitus
06/02/2010CN101716242A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
06/02/2010CN101716236A Chinese medicinal composition for adjunctively treating left ventricular insufficiency after acute myocardial infarction and preparation method thereof
06/02/2010CN101716235A Shuangdan granule and preparation process thereof
06/02/2010CN101716228A Medicament for treating cardiovascular and cerebrovascular diseases
06/02/2010CN101716220A Shielding alkaloid traditional Chinese medicine
06/02/2010CN101716218A Process for extracting rhododendron oil
06/02/2010CN101716213A Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof
06/02/2010CN101716206A Wild ginseng granules and preparation method thereof
06/02/2010CN101716200A Medicinal composition for invigorating circulation blood and dredging collaterals and clearing heat and releasing toxin and preparation method and application thereof
06/02/2010CN101716198A Method for preparing total ginkgo flavone glycosides slow-release capsules by applying attapulgite
06/02/2010CN101716197A Extractive of Taxus chinensis var.mairei leaves and preparation method
06/02/2010CN101716160A Creatine phosphate sodium oral solid preparation and preparation method thereof
06/02/2010CN101716158A Method for preparing matrine slow-release tablet by applying attapulgite
06/02/2010CN101716157A Metoprolol oral drug composite and preparation method thereof
06/02/2010CN101716152A Flunarizine hydrochloride pills and preparation method thereof
06/02/2010CN101716150A Acehytisine freeze-drying emulsion and reparation method thereof
1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 1595